InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Foster Alan Charles, Directeur Scientifique. Director active across 1 company, notably Otonomy, INC.. In total, 2 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €4k. Activity tracked since 14 January 2022. The latest transaction was filed on 25 March 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Foster Alan Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
1,827 股@ US$2.388100.0% 占其流量Common StockSEC:0001209191-22-021546:0
70,000 股0Common StockSEC:0001209191-22-003740:0
2 条申报中的 2 条
About Foster Alan Charles
Alan Charles Foster is Chief Scientific Officer at Otonomy, Inc. In this role, he is responsible for the scientific direction and research within the company. His expertise in science and clinical research is essential for the development of new treatments and technologies.
